Bullish Options Positioning Continues in Nektar Therapeutics (NKTR) -Susquehanna

Susquehanna options strategist Alison Edwards notes bullish options positioning in Nektar Therapeutics (NASDAQ: NKTR), as an opening investor bought 2k Jan 50 Calls for $3.15, adding to prior purchases this week of May and Jan2019 calls.

You May Also Be Interested In

• Autodesk (ADSK) call put ratio 1.4 calls to 1 puts into quarter results
• Hunterbrook Capital is short bonds issued by Sammons Financial Group and short Guggenheim Strategic Opportunities Fund
• Dollar Tree (DLTR) call put ratio 1 call to 1 put into quarter results